Abbvie says ABT-494 meets primary endpoint in two mid-stage studies
September 27, 2015
Permalink
Health

Abbvie says ABT-494 meets primary endpoint in two mid-stage studies

AbbVie said that it will return all rights to the compound to Galapagos, citing promising…

Continue Reading →

Shire offers to buy Baxter drug spinoff
August 4, 2015
Permalink
Health

Shire offers to buy Baxter drug spinoff

The Irish drugmaker Shire PLC Is offering to buy Baxalta for about $30 billion in…

Continue Reading →